Top Page
Zeotech Limited
(Sydney:ZEO)
Zeotech Limited (ZEO) vs. iShares MSCI Australia ETF (EWA)
Zeotech Limited Business Overview & Revenue Model
Zeotech Limited Financial Statement Overview
| Breakdown | TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 931.15K | 0.00 | 775.12K | 1.07M | 645.64K | 178.29K |
| Gross Profit | 838.19K | -182.88K | 775.12K | 910.42K | 618.92K | 173.13K |
| EBITDA | -4.14M | -5.05M | -3.62M | -3.30M | -4.84M | -2.91M |
| Net Income | -4.41M | -4.41M | -5.53M | -2.47M | -4.23M | -2.92M |
Balance Sheet | ||||||
| Total Assets | 12.94M | 12.94M | 12.84M | 14.95M | 9.52M | 11.52M |
| Cash, Cash Equivalents and Short-Term Investments | 2.35M | 2.35M | 2.27M | 4.21M | 3.05M | 5.85M |
| Total Debt | 1.27M | 1.27M | 816.77K | 366.03K | 476.00K | 0.00 |
| Total Liabilities | 1.91M | 1.91M | 1.30M | 741.92K | 659.46K | 159.88K |
| Stockholders Equity | 11.03M | 11.03M | 11.54M | 14.21M | 8.86M | 11.36M |
Cash Flow | ||||||
| Free Cash Flow | -3.50M | -3.50M | -2.60M | -3.64M | -2.79M | -2.73M |
| Operating Cash Flow | -3.44M | -3.44M | -2.56M | -1.75M | -2.47M | -2.18M |
| Investing Cash Flow | -164.74K | -164.74K | -104.94K | -1.89M | -465.04K | -550.47K |
| Financing Cash Flow | 3.69M | 3.69M | 717.85K | 4.95M | -11.62K | 7.02M |
Zeotech Limited Technical Analysis
Zeotech Limited Peers Comparison
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
61 Neutral | $10.43B | 7.12 | -0.05% | 2.87% | 2.86% | -36.73% | |
52 Neutral | AU$204.47M | -21.43 | -20.60% | ― | ― | 7.28% | |
50 Neutral | AU$92.08M | -3.40 | -18.67% | ― | ― | 53.31% | |
46 Neutral | AU$133.11M | -22.86 | -8.25% | ― | ― | -55.56% | |
44 Neutral | AU$164.59M | -33.75 | -39.06% | ― | ― | 25.00% | |
44 Neutral | AU$461.97M | -6.00 | -84.61% | ― | 149.43% | 1.20% | |
43 Neutral | AU$207.74M | -5.57 | -12.73% | ― | 2.00% | 8.82% |
Zeotech Limited Corporate Events
Zeotech Limited has disclosed a change in the interests of director Shane Michael Graham, detailing the issue of a substantial parcel of options and performance rights linked to the company’s employee securities incentive plan. Graham, through his superannuation vehicle and directly, now holds 20 million options and 30 million performance rights in various classes, representing a significant increase in equity-based remuneration that further aligns his incentives with long-term shareholder value and signals the company’s continued use of performance-linked securities to retain and motivate key executives.
The most recent analyst rating on (AU:ZEO) stock is a Buy with a A$0.15 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has notified the market of the issuance of 20 million unquoted options under an employee incentive scheme, each exercisable at A$0.10 and expiring on 7 April 2028. The move, disclosed via an Appendix 3G filing, expands the company’s pool of equity-based incentives for staff and insiders, potentially aligning employee interests with long‑term shareholder value but also introducing prospective dilution if the options are exercised.
The most recent analyst rating on (AU:ZEO) stock is a Buy with a A$0.15 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has notified the market of the issue of 40 million unquoted performance rights under its employee incentive scheme, with the new securities not intended to be quoted on the ASX. The move expands the company’s pool of equity-based remuneration, signalling an increased use of performance-linked incentives to align staff and management interests with shareholder value, though it may also introduce potential future dilution for existing investors depending on vesting outcomes.
The most recent analyst rating on (AU:ZEO) stock is a Buy with a A$0.15 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has achieved significant milestones at its Toondoon Kaolin Project, completing a large-scale test pit and key approval surveys. These achievements provide valuable data for mine planning, validate kaolin logistics for direct shipping ore trials, and accelerate the development of its AusPozz™ product and associated feasibility studies. The progress aligns with Zeotech’s broader strategy to fast-track kaolin mining operations and further enhance its market position in the materials sector.
The most recent analyst rating on (AU:ZEO) stock is a Buy with a A$0.15 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has issued quoted securities without disclosure to investors, in compliance with Section 708A of the Corporations Act 2001. The company confirms adherence to relevant legal provisions and states there is no excluded information requiring disclosure, indicating a transparent and compliant approach to its securities issuance.
The most recent analyst rating on (AU:ZEO) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has announced the issuance of 2,000,000 fully paid ordinary securities, which will be quoted on the Australian Securities Exchange (ASX) under the code ZEO. This move is part of the company’s strategic efforts to enhance its market presence and provide additional value to its stakeholders by leveraging its innovative technologies.
The most recent analyst rating on (AU:ZEO) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited announced the results of its Annual General Meeting held on November 28, 2025, where all resolutions were passed. Key decisions included the adoption of the remuneration report, re-election and election of directors, approval of a 10% placement capacity, and the issuance of options and incentive performance rights to directors. These outcomes reflect strong shareholder support and are expected to bolster the company’s governance and strategic initiatives.
The most recent analyst rating on (AU:ZEO) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has released a presentation regarding its AusPozz Project, highlighting a Preliminary Feasibility Study (PFS) that assesses the project’s technical and economic viability. While the PFS provides insights into potential mining, processing, and infrastructure requirements, it is not final, and further studies are needed to confirm economic viability. The company acknowledges the need for significant funding to achieve the outcomes indicated in the PFS, and there is uncertainty regarding the availability of such funding. Investors are cautioned against making investment decisions solely based on the PFS results.
The most recent analyst rating on (AU:ZEO) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited has received a cash refund of $960,762.21 from the Australian Federal Government’s R&D Tax Incentive Program for its research and development activities in the financial year ending June 2025. This refund supports the company’s efforts in developing high reactivity metakaolin for low-carbon cement and concrete, and its proprietary mineral processing technology for sustainable zeolite production and methane emissions control. The R&D loan secured earlier in the year has been repaid, indicating a positive impact on the company’s financial stability and its ongoing commitment to innovation in sustainable materials.
The most recent analyst rating on (AU:ZEO) stock is a Hold with a A$0.08 price target. To see the full list of analyst forecasts on Zeotech Limited stock, see the AU:ZEO Stock Forecast page.
Zeotech Limited announced that an independent peer review by BG&E Pty Ltd validated the performance of its product, AusPozz™, in concrete mix trials. The review confirmed that AusPozz™ enhances concrete strength, reduces shrinkage, and mitigates Alkali-Silica Reaction risks, positioning it as a compelling solution for sustainable construction. This validation supports Zeotech’s market positioning and commitment to providing high-performance, low-carbon building materials.
Zeotech Limited has signed a non-binding Letter of Intent with Bisley & Company to explore the commercialization and distribution of its AusPozz™ metakaolin products. This collaboration aims to tap into Bisley’s extensive distribution network and market expertise to assess and develop a strategic framework for introducing AusPozz™ to both domestic and international markets, thereby enhancing Zeotech’s market reach and potential customer base.
Zeotech Limited has released a preliminary feasibility study for its AusPozz Project, which focuses on producing low-carbon concrete. The study indicates potential technical and economic viability but requires further evaluation, including a definitive feasibility study, to confirm the project’s economic development case. The company highlights the need for significant funding and acknowledges uncertainties that could impact project outcomes and shareholder value.
Zeotech Limited has issued new quoted securities without disclosure to investors, relying on specific provisions of the Corporations Act 2001. The company confirms compliance with relevant legislative requirements and states there is no excluded information that needs to be disclosed, indicating a transparent and compliant operational approach.
Zeotech Limited announced the issuance of 1,000,000 fully paid ordinary securities, which will be quoted on the ASX. This move is part of an employee incentive scheme, indicating the company’s efforts to align employee interests with its growth and market objectives. The issuance could enhance Zeotech’s market presence and operational capacity, potentially benefiting stakeholders by increasing company value and market competitiveness.
Zeotech Limited has announced the issuance of 1,742,625 ordinary fully paid shares as part of their application for quotation of securities on the Australian Securities Exchange (ASX). This move is aimed at satisfying services, indicating a strategic step in the company’s operational activities. The announcement reflects Zeotech’s ongoing efforts to enhance its market presence and operational capabilities by leveraging its financial instruments.
Zeotech Limited announced the cessation of 500,000 securities due to the expiry of options that were not exercised by the deadline of October 31, 2025. This development may impact the company’s capital structure and could influence investor perceptions regarding the company’s financial strategies and market positioning.
Zeotech Limited has announced its Annual General Meeting (AGM) for shareholders, scheduled for November 28, 2025, in Brisbane. The company has provided details on how shareholders can attend and vote, either in person or by proxy, emphasizing the importance of participating in the decision-making process. This meeting is crucial for stakeholders as it will involve voting on resolutions that could impact the company’s future operations and strategic direction.
Zeotech Limited has announced its Annual General Meeting (AGM) scheduled for November 28, 2025, at The Westin Brisbane. The meeting will cover the agenda and resolutions for the upcoming year, and shareholders are encouraged to review the Notice of Meeting, Explanatory Statement, and Proxy Form available on the company’s website. This AGM is a significant event for stakeholders as it outlines the company’s strategic direction and operational priorities for the coming year.
Zeotech Limited has made significant strides in its operations during the quarter ending September 2025, highlighted by a $204 million binding offtake agreement with Jiangsu Mineral Sources International Trading Co. for its kaolin products. The company also completed a large-scale demonstration pour of its AusPozz™ product, validating its potential as a low-carbon construction material, and entered a non-binding MOU with Laing O’Rourke to explore further trials. Additionally, Zeotech raised $13 million to support its mining readiness activities and expand its kaolin resource, positioning itself as a leader in sustainable construction solutions.
Zeotech Limited has announced the quotation of 2,500,000 fully paid ordinary securities on the ASX, effective October 21, 2025. This move is part of the company’s strategic efforts to strengthen its financial position and expand its market presence, potentially impacting its operations and offering new opportunities for stakeholders.
Zeotech Limited has signed a non-binding Memorandum of Understanding with Cement Australia to collaborate on the development of AusPozz™, a high-reactivity metakaolin product aimed at reducing carbon emissions in the construction industry. This partnership will involve the exchange of technical information and testing to assess the product’s viability as a supplementary cementitious material, with the potential to advance the commercial-scale production of low-carbon concrete solutions.
Zeotech Limited has released a preliminary feasibility study (PFS) for its AusPozz Project, which evaluates the technical and economic viability of producing low-carbon concrete. While the PFS suggests potential, further evaluations, including a definitive feasibility study, are needed to confirm the project’s economic viability. The company acknowledges the need for significant funding to achieve the project’s goals and warns of potential dilution of shares or changes in ownership if alternative funding strategies are pursued.
Zeotech Limited has issued new quoted securities without disclosure to investors, in compliance with Section 708A of the Corporations Act 2001. This move indicates the company’s adherence to regulatory requirements and suggests a strategic effort to enhance its financial flexibility, potentially impacting its market positioning and stakeholder interests.
Zeotech Limited has announced a new issuance of 162,500,000 fully paid ordinary securities to be quoted on the Australian Securities Exchange (ASX) under the code ZEO. This move is part of a previously announced transaction and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its stakeholders positively by increasing liquidity and investor interest.